Mark Cornell Manning,Zahra Shahrokh,Dave Nichols,Phillip M Levesque,Ryan Erik Holcomb
申请号：
US15950974
公开号：
US10493149B2
申请日:
2018.04.11
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
